Qalsody
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Qalsody, covering 2023-04-25 to 2026-04-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)